Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Operating Expenses (2019 - 2025)

Historic Operating Expenses for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $20.3 million.

  • Korro Bio's Operating Expenses fell 1272.97% to $20.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.9 million, marking a year-over-year increase of 637.72%. This contributed to the annual value of $94.2 million for FY2024, which is 1141.2% up from last year.
  • According to the latest figures from Q3 2025, Korro Bio's Operating Expenses is $20.3 million, which was down 1272.97% from $28.7 million recorded in Q2 2025.
  • Korro Bio's Operating Expenses' 5-year high stood at $28.7 million during Q2 2025, with a 5-year trough of -$5.8 million in Q4 2022.
  • Its 5-year average for Operating Expenses is $21.7 million, with a median of $23.3 million in 2022.
  • Its Operating Expenses has fluctuated over the past 5 years, first plummeted by 12719.23% in 2022, then surged by 56303.37% in 2023.
  • Korro Bio's Operating Expenses (Quarter) stood at $21.4 million in 2021, then crashed by 127.19% to -$5.8 million in 2022, then surged by 563.03% to $26.9 million in 2023, then fell by 5.88% to $25.3 million in 2024, then dropped by 19.69% to $20.3 million in 2025.
  • Its Operating Expenses was $20.3 million in Q3 2025, compared to $28.7 million in Q2 2025 and $27.6 million in Q1 2025.